Journal profile · SUBSTANCE ABUSE
Journal of Addictive Diseases
ISSN 1055-0887 · eISSN 1545-0848 · Taylor & Francis
Journal of Addictive Diseases: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.85; hybrid open access; APC charged, amount not published; review about 28 days (first decision after review, publisher); acceptance rate 19% (journal website); 48 articles in 2025; indexed in SSCI and Scopus.
Scope
Aims, scope and focus
Journal of Addictive Diseases is published by Taylor & Francis and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment and HIV, Drug Use, Sexual Risk, together about 41.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
An essential, comprehensive resource covering the full range of addiction research, the Journal of Addictive Diseases provides original research on the vital issues and the clinical skills necessary to ensure effective practice. The journal publishes the latest research, treatments, and public policy issues in addiction medicine, presented in a fully integrated, multi-specialty perspective. Top researchers and respected leaders in addiction issues share their knowledge and insights on the most important research and practical applications. The Journal of Addictive Diseases publishes original research and reviews of the latest relevant findings in etiology, epidemiology, and clinical care. The journal is known for its scholarly commitment to the field and reflects the highest standards of investigation, clinical practice, medical education, and evaluation of patient care. The journal presents material from diverse aspects of the field: basic science, clinical aspects, self-help programs and philosophy, medical training issues, treatment outcomes, and treatment evaluation perspectives, to provide the reader with valuable information from a wide range of disciplines. The journal operates a double anonymized peer review policy.
From the journal's Aims & Scope
Research area (LetPub): SUBSTANCE ABUSE
Editor-in-chief R. GREGORY LANDEPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Substance Abuse Treatment and OutcomesMedicine22%
- Opioid Use Disorder TreatmentMedicine14.9%
- HIV, Drug Use, Sexual RiskMedicine5.1%
- Prenatal Substance Exposure EffectsMedicine5.1%
- Smoking Behavior and CessationMedicine5%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics4.6%
- Alcohol Consumption and Health EffectsMedicine4.4%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbasePsycINFOPublisher website
Other: Criminal Justice Abstracts, Current Abstracts, EBSCOhost Online Research Databases, Family Index Database, Index Copernicus, Social Care Institute, SOCIndex for Excellence, Social Services Abstracts, Social Work Abstracts, Sociological Abstracts, TOCPremier
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.85LetPub ·
- Impact factor (publisher) 2025
- 1.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.7Publisher website ·
- CiteScore 2026-06
- 3.2LetPub ·
- CiteScore (publisher) 2025
- 3.2Publisher website ·
- SJR 2026-06
- 0.51LetPub ·
- SJR (publisher) 2025
- 0.51Publisher website ·
- SNIP 2026-06
- 0.55LetPub ·
- SNIP (publisher) 2025
- 0.55Publisher website ·
- h-index
- 84OpenAlex ·
- i10-index
- 825OpenAlex ·
- 2-year mean citedness
- 1.78OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 7.97%LetPub ·
Volume
- Articles per year
- 43LetPub ·
- Downloads per year (publisher)
- 106,000Publisher website ·
Articles by year OpenAlex count · 1,704 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 43 | 4 | 14 |
| 2025 | 48 | 5 | 81 |
| 2024 | 55 | 20 | 165 |
| 2023 | 57 | 14 | 266 |
| 2022 | 75 | 19 | 384 |
| 2021 | 79 | 8 | 1,017 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
28 daysfirst decision after review
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Acceptance rate (publisher)
- 19%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 28 daysPublisher website ·
- Acceptance to publication
- 29 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Hybrid open access (Open Select) Model summary
Journal of Addictive Diseases is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverabili…
Source ↗Publisher website ·- Peer review
Double anonymized peer review Model summary
The journal operates a double anonymized peer review policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor & Francis
- ISSN
- 1055-0887
- Electronic ISSN
- 1545-0848
- Latest issue on the website
- Volume 44, Issue 4 (2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Addictive Diseases
What CAS zone is Journal of Addictive Diseases in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Addictive Diseases is in Zone 4 of Medicine, and in Zone 4 of the minor category Substance Abuse. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Addictive Diseases?
The latest impact factor listed by LetPub is 1.85; CiteScore 3.2, h-index 84.
How long does peer review take at Journal of Addictive Diseases?
The publisher reports about 28 days (first decision after review); the journal's website gives an acceptance rate of 19%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Addictive Diseases?
According to LetPub and DOAJ records, Journal of Addictive Diseases is indexed in SSCI and Scopus. The journal's website also lists MEDLINE, PubMed, Embase and PsycINFO; that list has not been checked against each database.
Is Journal of Addictive Diseases open access, and what is the APC?
Journal of Addictive Diseases is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .